English | Español
Patient Daily | Feb 5, 2026

Roche reports strong phase II results for obesity drug candidate CT-388
Patient Daily | Feb 5, 2026

Prognostic nutritional index linked to outcomes in advanced liver cancer therapy
Patient Daily | Feb 5, 2026

Boston University receives $2M grant for Parkinson’s gait device clinical trial
Patient Daily | Feb 5, 2026

UH research examines links between trauma-related anxieties and alcohol use in sexual violence victims
Patient Daily | Feb 5, 2026

Researchers develop smart contact lens for continuous eye pressure monitoring
Patient Daily | Feb 5, 2026

Study finds industrial chemical PFOA may harm fertility by disrupting embryo implantation
Patient Daily | Feb 5, 2026

Review links modern lifestyle factors with disruptions in gut microbiome
Patient Daily | Feb 5, 2026

Study links richer social environments with improved cognition among older adults

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Palbociclib shows promise extending survival in HR+, HER2+ metastatic breast cancer